The European Society of Cardiology has recently published guidelines regarding the management of pericarditis and myocarditis.

Chapter 1, page 11 This code is basic but allows the reader to gain insight into key elements for several other projects in this book. It combines two pieces of code that are listed in the examples ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

MANILA, Philippines — The expanded number coding scheme is suspended amid inclement weather on Monday, Sept. 1, the Metropolitan Manila Development Authority (MMDA) announced. “Be careful when driving ...

Earlier, less-invasive treatment is at the core of the latest iteration of the joint European Society of Cardiology/European Association for Cardio-Thoracic Surgery (ESC/EACTS) valvular heart disease ...

Alibaba Group Holding-backed Moonshot AI is set to release an updated version of the Kimi K2 artificial intelligence model that took the world by storm in July. On Wednesday, the Beijing-based ...

CLEVELAND, Ohio (WOIO/WUAB) - WUAB Cleveland’s 43 will switch from The CW Network to MyNetworkTV on Sept. 1. The affiliation change means all new programming for you, including Cleveland’s only news ...

The following is a transcript of the podcast episode: Rachael Robertson: Hey everybody. Welcome to MedPod Today, the podcast series where MedPage Today reporters share deeper insight into the week's ...

Findings from COLLIGO-HCM reinforce Camzyos’ efficacy and safety profile in reducing left ventricular outflow tract (LVOT) obstruction and improving symptom burden in a racially diverse, global ...

In the wake of the latest developments regarding the Eurovision Song Contest and the current geopolitical global scenario, ESCToday has reached out to the EBU to shed more light on the 2026 Eurovision ...

Bayer and MSD's hopes of expanding the use of their sGC stimulator Verquvo in heart failure have been dashed by a failed phase 3 trial. The results of the 6,105-patient VICTOR study showed that ...